Since the IC score only considers PD-L1 expression in immune cells—the TPS includes PD-L1 expression in cancer cells and the CPS includes PD-L1 expression in cancer and immune cells—it underlines that the main PD-L1 expression in hot tumors is in cancer cells. This evidence concerns the gene CD274 and cancer.